Ramsay Générale de Santé S.A.
GDS.PA · PAR
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | €2,734,800 | €1,253,600 | €1,253,600 | €1,305,200 |
| % Growth | 118.2% | 0% | -4% | – |
| Cost of Goods Sold | €2,185,500 | €922,000 | €922,000 | €932,400 |
| Gross Profit | €549,300 | €331,600 | €331,600 | €372,800 |
| % Margin | 20.1% | 26.5% | 26.5% | 28.6% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €261,800 | €20,000 | €20,000 | €7,900 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €165,800 | €280,500 | €280,500 | €346,300 |
| Operating Expenses | €427,600 | €300,500 | €300,500 | €354,200 |
| Operating Income | €121,700 | €65,700 | €31,100 | €18,600 |
| % Margin | 4.5% | 5.2% | 2.5% | 1.4% |
| Other Income/Exp. Net | -€112,500 | -€108,300 | -€52,400 | -€43,900 |
| Pre-Tax Income | €9,200 | -€42,600 | -€21,300 | -€25,300 |
| Tax Expense | €4,800 | -€3,200 | -€1,600 | -€2,100 |
| Net Income | -€11,000 | -€21,550 | -€21,550 | -€33,300 |
| % Margin | -0.4% | -1.7% | -1.7% | -2.6% |
| EPS | -0.1 | -0.2 | -0.2 | -0.29 |
| % Growth | 50.2% | 0% | 31% | – |
| EPS Diluted | -0.1 | -0.2 | -0.2 | -0.29 |
| Weighted Avg Shares Out | 110,357 | 110,357 | 110,357 | 114,737 |
| Weighted Avg Shares Out Dil | 110,357 | 110,357 | 110,357 | 114,737 |
| Supplemental Information | – | – | – | – |
| Interest Income | €2,600 | €2,100 | €0 | €14,000 |
| Interest Expense | €106,700 | €0 | €47,400 | €129,100 |
| Depreciation & Amortization | €215,500 | €41,800 | €41,800 | €119,100 |
| EBITDA | €330,300 | €71,950 | €71,950 | €120,500 |
| % Margin | 12.1% | 5.7% | 5.7% | 9.2% |